These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23265149)

  • 21. Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis.
    Katafuchi T; Makishima M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary procyanidins selectively modulate intestinal farnesoid X receptor-regulated gene expression to alter enterohepatic bile acid recirculation: elucidation of a novel mechanism to reduce triglyceridemia.
    Heidker RM; Caiozzi GC; Ricketts ML
    Mol Nutr Food Res; 2016 Apr; 60(4):727-36. PubMed ID: 26718753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
    Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
    J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FXR signaling in the enterohepatic system.
    Matsubara T; Li F; Gonzalez FJ
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):17-29. PubMed ID: 22609541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
    Sun L; Cai J; Gonzalez FJ
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Farnesoid X receptor: from medicinal chemistry to clinical applications.
    Fiorucci S; Mencarelli A; Distrutti E; Zampella A
    Future Med Chem; 2012 May; 4(7):877-91. PubMed ID: 22571613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role of the bile salt receptor FXR in atherosclerosis.
    Hageman J; Herrema H; Groen AK; Kuipers F
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1519-28. PubMed ID: 20631352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
    Prawitt J; Caron S; Staels B
    Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
    Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
    Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.
    Di Ciaula A; Bonfrate L; Baj J; Khalil M; Garruti G; Stellaard F; Wang HH; Wang DQ; Portincasa P
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine.
    Gadaleta RM; Oldenburg B; Willemsen EC; Spit M; Murzilli S; Salvatore L; Klomp LW; Siersema PD; van Erpecum KJ; van Mil SW
    Biochim Biophys Acta; 2011 Aug; 1812(8):851-8. PubMed ID: 21540105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease.
    Wilson A; Almousa A; Teft WA; Kim RB
    Sci Rep; 2020 Feb; 10(1):1866. PubMed ID: 32024859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FXR: a metabolic regulator and cell protector.
    Wang YD; Chen WD; Moore DD; Huang W
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts.
    Houten SM; Auwerx J
    Ann Med; 2004; 36(7):482-91. PubMed ID: 15513299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic cognitive dysfunction is associated with increased bile acids in liver and activation of bile acid signaling in intestine.
    Wang X; Wang F; Zhang Y; Xiong H; Zhang Y; Zhuang P; Zhang Y
    Toxicol Lett; 2018 May; 287():10-22. PubMed ID: 29382564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19.
    Piglionica M; Cariello M; Moschetta A
    Curr Opin Pharmacol; 2018 Dec; 43():93-98. PubMed ID: 30223181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.